Untargeted metabolomic analysis of pregnant women exposure to perfluorooctanoic acid at different degrees

Highlights

● Metabolome can distinguish pregnant women exposure to PFOA at different degrees.

● Metabolome can reveal the metabolic changes of pregnant women exposure to PFOA.

● PFOA exposure degrees could affect the GSH metabolism of pregnant women.

● PFOA exposure degrees could change the microbiota metabolism of pregnant women.

Abstract

Perfluorooctanoic acid (PFOA) is a novel type of persistent synthetic organic pollutant, and its exposure on pregnant women can cause some adverse effects, such as pregnancy-induced hypertension, gestational diabetes mellitus, and preeclampsia. Therefore, understanding the metabolic changes caused by PFOA exposure is of great significance to protect pregnant women from its adverse effects. In this study, the metabolomes from the urine samples of pregnant women exposure to PFOA at different degrees were analyzed by GC-MS and LC-MS. The samples in different groups were distinguished and the differential metabolites were screened based on the VIP value, FC, and P-value of each comparison group through multivariate statistical analysis. The pathways related to differential metabolites were searched to reveal the effects of PFOA exposure on metabolic changes in pregnant women at different degrees. Finally, the ROC of differential metabolites was performed, and the differential metabolites with large area under the curve (AUC) values were selected and compared to identify the mutually differential metabolites. Meanwhile, these metabolites were fitted with a multivariable to explore if they could be used to distinguish different groups. The quantitative comparison of mutually differential metabolites revealed that the levels of L-cysteine, glycine, and 5-aminovaleric acid were positively correlated with the degree of PFOA exposure, indicating that different degrees of PFOA exposure could affect the synthesis or degradation of GSH and change the metabolism of oral or intestinal microbiota. Additionally, they may cause oxidative stress and abnormal fat metabolism in pregnant women.

Graphical abstract

Keywords

Perfluorooctanoic acid / Exposure / Pregnant women / Metabolomic / GSH / Microbiota metabolism

References

[1] AldereteT L, JinR, WalkerD I, ValviD, ChenZ, JonesD P, PengC, GillilandF D, BerhaneK, ContiD V, GoranM I, ChatziL. (2019). Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: a proof-of-concept analysis. Environment International, 126 : 445– 453

[2] AraziH, EghbaliE, SuzukiK. (2021). Creatine supplementation, physical exercise and oxidative stress markers: a review of the mechanisms and effectiveness. Nutrients, 13( 3): 869

[3] AsantewaaG, HarrisI S. (2021). Glutathione and its precursors in cancer. Current Opinion in Biotechnology, 68 : 292– 299

[4] AvanasiR, ShinH M, VieiraV M, BartellS M. (2016). Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population. Environmental Research, 146 : 299– 307

[5] BaldwinP E, CainJ R, FletcherR, JonesK, WarrenN ( 2007). Dehydroabietic acid as a biomarker for exposure to colophony. Occupational Medicine (Oxford, England), 57( 5): 362– 366

[6] BehrA C, KwiatkowskiA, StåhlmanM, SchmidtF F, LuckertC, BraeuningA, BuhrkeT. (2020). Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells. Archives of Toxicology, 94( 5): 1673– 1686

[7] BishtV, NashK, XuY, AgarwalP, BoschS, GkoutosG V, AcharjeeA. (2021). Integration of the microbiome, metabolome and transcriptomics data identified novel metabolic pathway regulation in colorectal cancer. International Journal of Molecular Sciences, 22( 11): 5763

[8] CialièRosso M, StiloF, SquaraS, LibertoE, MaiS, MeleC, MarzulloP, AimarettiG, ReichenbachS E, CollinoM, BicchiC, CorderoC. (2021). Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry. Analytical and Bioanalytical Chemistry, 413( 2): 403– 418

[9] CluettR, SeshasayeeS M, RokoffL B, Rifas-ShimanS L, YeX, CalafatA M, GoldD R, CoullB, GordonC M, RosenC J, OkenE, SagivS K, FleischA F. (2019). Per- and polyfluoroalkyl substance plasma concentrations and bone mineral density in midchildhood: a cross-sectional study (Project Viva, United States). Environmental Health Perspectives, 127( 8): 087006

[10] FengX, ChenX, YangY, YangL, ZhuY, ShanG, ZhuL, ZhangS. (2021). External and internal human exposure to PFOA and HFPOs around a mega fluorochemical industrial park, China: differences and implications. Environment International, 157 : 106824

[11] FentonS E, DucatmanA, BoobisA, DeWittJ C, LauC, NgC, SmithJ S, RobertsS M. (2021). Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environmental Toxicology and Chemistry, 40( 3): 606– 630

[12] GebreabK Y, EezaM N H, BaiT, Zuberi Z, MatysikJ, O'sheaK E, AliaA, BerryJ P ( 2020). Comparative toxicometabolomics of perfluorooctanoic acid (PFOA) and next-generation perfluoroalkyl substances. Environmental Pollution, 265(Pt A): 114928

[13] GyllenhammarI, BenskinJ P, SandblomO, BergerU, AhrensL, LignellS, WibergK, GlynnA. (2018). Perfluoroalkyl acids (PFAAs) in serum from 2–4-month-old infants: influence of maternal serum concentration, gestational age, breast-feeding, and contaminated drinking water. Environmental Science & Technology, 52( 12): 7101– 7110

[14] HalldorssonT I, RytterD, HaugL S, BechB H, DanielsenI, BecherG, HenriksenT B, OlsenS F. (2012). Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environmental Health Perspectives, 120( 5): 668– 673

[15] KudoN, KawashimaY. (2003). Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. Journal of Toxicological Sciences, 28( 2): 49– 57

[16] LamJ, KoustasE, SuttonP, JohnsonP I, AtchleyD S, SenS, RobinsonK A, AxelradD A, WoodruffT J. (2014). The Navigation Guide−evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environmental Health Perspectives, 122( 10): 1040– 1051

[17] LinP D, CardenasA, HauserR, GoldD R, KleinmanK P, HivertM F, FleischA F, CalafatA M, WebsterT F, HortonE S, OkenE. (2019). Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study. Environment International, 129 : 343– 353

[18] LvD, GuY, GuoM, HouP, LiY, WuR. (2019). Perfluorooctanoic acid exposure induces apoptosis in SMMC-7721 hepatocellular cancer cells. Environmental Pollution, 247 : 509– 514

[19] PodderA, SadmaniA H M A, ReinhartD, ChangN B, GoelR. (2021). Per and poly-fluoroalkyl substances (PFAS) as a contaminant of emerging concern in surface water: A transboundary review of their occurrences and toxicity effects. Journal of Hazardous Materials, 419 : 126361

[20] QiuX, MaJ, LiP, GengZ, SunC, WangD, XuW. (2020). Development of indirect competitive ELISA for determination of dehydroabietic acid in duck skin and comparison with the HPLC method. Poultry Science, 99( 6): 3280– 3285

[21] SalihovicS, FallT, GannaA, BroecklingC D, PrenniJ E, HyötyläinenT, KärrmanA, LindP M, IngelssonE, LindL. (2019). Identification of metabolic profiles associated with human exposure to perfluoroalkyl substances. Journal of Exposure Science & Environmental Epidemiology, 29( 2): 196– 205

[22] SavitzD A, SteinC R, BartellS M, ElstonB, GongJ, ShinH M, WelleniusG A ( 2012). Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology (Cambridge, Mass.), 23( 3): 386– 392

[23] SteenlandK, FletcherT, SteinC R, BartellS M, DarrowL, Lopez-EspinosaM J, Barry RyanP, SavitzD A. (2020). Review: evolution of evidence on PFOA and health following the assessments of the C8 Science Panel. Environment International, 145 : 106125

[24] VanNoyB N, LamJ, ZotaA R. (2018). Breastfeeding as a predictor of serum concentrations of per- and polyfluorinated alkyl substances in reproductive-aged women and young children: a rapid systematic review. Current Environmental Health Reports, 5( 2): 213– 224

[25] WangJ, ZhangJ, FanY, LiZ, TaoC, YanW, NiuR, HuangY, XuQ, WangX, XuQ, HanL, LuC. (2022). Association between per- and polyfluoroalkyl substances and risk of gestational diabetes mellitus. International Journal of Hygiene and Environmental Health, 240 : 113904

[26] WikströmS, LinP I, LindhC H, ShuH, BornehagC G. (2020). Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight. Pediatric Research, 87( 6): 1093– 1099

[27] XuT Guo Y LuJ ShanJ LinL Qian W ChenW WangJ LvX Ke M, . (2021). Untargeted serum metabolomics and potential biomarkers for Sjogren’s syndrome. Clinical and Experimental Rheumatology, 39 133 (Suppl 6): 23– 29

[28] ZengW, HuangK E, LuoY, LiD X, ChenW, YuX Q, KeX H. (2020). Nontargeted urine metabolomics analysis of the protective and therapeutic effects of Citri Reticulatae Chachiensis Pericarpium on high-fat feed-induced hyperlipidemia in rats. Biomedical Chromatography, 34( 4): e4795

[29] ZhangH, HeJ, LiN, GaoN, DuQ, ChenB, ChenF, ShanX, DingY, ZhuW, WuY, TangJ, JiaX. (2019). Lipid accumulation responses in the liver of Rana nigromaculata induced by perfluorooctanoic acid (PFOA). Ecotoxicology and Environmental Safety, 167 : 29– 35

[30] ZhangY, BeesoonS, ZhuL, MartinJ W. (2013). Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environmental Science & Technology, 47( 18): 10619– 10627

[31] ZhangY, ZhangL, BaoJ, LiuL, WangX. (2021). Perfluorooctanoic acid exposure in early pregnancy induces oxidative stress in mice uterus and liver. Environmental Science and Pollution Research International, 28( 46): 66355– 66365

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Nos. 81874307 and 21874088); the Shanghai Science and Technology Commission Scientific Research Project (Nos. 19142203100, 20142200400, 18490731500, and 19DZ2202200); the National Facility for Translational Medicine, Shanghai (No. TMSK-2020-131).

Ethics Approval and Consent for Participate Statament

All participants provided written informed consent for themselves and their neonates. This study was approved by the ethical committees at theShanghai Institute of Planned Parenthood Research.

Author Contributions

Kaige Yang: Methodology, Visualization, Formal analysis. Zhouyi Zhang: Formal analysis, Validation. Kangdie Hu: Investigation. Bo Peng: Conceptualization, Methodology. Weiwei Wang: Investigation. Hong Liang: Resources, Supervision. Mingyuan Wu: Methodology. Yan Wang: Conceptualization, Data Curation. Chao Yan: Conceptualization.

Electronic Supplementary Material

Supplementary material is available in the online version of this article at https://doi.org/10.1007/s11783-023-1628-x and is accessible for authorized users.

RIGHTS & PERMISSIONS

2023 Higher Education Press